Amedica Corporation (AMDA) Shares are Down -14.85%

Amedica Corporation (AMDA) has risen sharply, recording gains of 7.77% in the past 4 weeks. However, the stock has corrected -14.85% in the past 1 week, providing a good buying opportunity on dips. On a relative basis, the stock has outperformed the S&P 500 by 7.91% in the past 4 weeks, but has underperformed the S&P 500 in the past 1 week.

The stock has recorded a 20-day Moving Average of 1.1% and the 50-Day Moving Average is 6.62%.The 200 Day SMA reached 45.58%. Amedica Corporation has dropped 38.57% during the last 3-month period . Year-to-Date the stock performance stands at -51.82%.


Amedica Corporation (NASDAQ:AMDA): The stock opened in the green at $0.8888 on Friday, but the bulls found it difficult to push the prices higher. The stock reached a high of $0.8888 and a low of $0.82 for the day. The stock did not find buyers even at the lows and closed at $0.86 recording a loss of -1.15%. 1,257,729 shares exchanged hands during the trading day. The stock had closed at $0.87 in the previous days trading.

Amedica Corporation is a commercial biomaterial company. The Company is a vertically integrated silicon nitride orthopedic medical device manufacturer focused on using its silicon nitride technology platform to develop, manufacture and sell a range of medical devices. The Company markets spinal fusion products and are developing products for use in total hip and knee joint replacements. The Company markets its Valeo family of silicon nitride interbody spinal fusion devices in the United States and Europe for use in the cervical and thoracolumbar areas of the spine. The Companys Valeo interbody spinal fusion devices include Anterior Lumbar, Posterior Lumbar, Oblique Lumbar, Transforaminal Lumbar, Cervical and Corpectomy. In addition to its silicon nitride-based spinal fusion products, the Company markets a line of non-silicon nitride spinal fusion products, which allows it to provide surgeons and hospitals with a range of products.

Leave a Reply

Get Pre-Market Alerts!

Get Pre-Market Analysts' Upgrades, Downgrades, Earnings & Initiations with our FREE daily email newsletter.